ライフサイエンスコーパス: creatinine

1 lyses of biomarkers is to adjust for urinary creatinine.

2 oagulation, incidence of encephalopathy, and creatinine.

3 ong with decreased levels of ngal and plasma creatinine.

4 timated glomerular filtration rate and lower creatinine.

5 d at earlier time points compared with serum creatinine.

6 se of 50% or more from preprocedural to peak creatinine.

7 ty when assessed by serum cystatin C than by creatinine.

8 /5.67 micromol/L and 39.7/33.9 micromol/mmol creatinine.

9 ed equation (r(2) = 74.6%) was GFR = 45.9 x (creatinine(-0.836) ) x (urea(-0.229) ) x (international

10 Neurological and renal impairments (serum creatinine, 0.87+/-0.20; median, 0.80; interquartile ran

11 pe 2 diabetes mellitus and renal impairment (creatinine 1.5-3 mg/dL) who were candidates for coronary

12 atinine, 140.3 mumol/L) and ABOc recipients (creatinine, 140.2 mumol/L) (P = 0.99), with no significa

13 Graft function was similar between ABOi (creatinine, 140.3 mumol/L) and ABOc recipients (creatini

14 had an increased risk for doubled levels of creatinine (1985 events; adjusted hazard ratio [HR], 1.2

15 th glomerular filtration rate estimated from creatinine, 44% versus 26%.

16 SigmaAs, iAs%, MMA%, and DMA% was 4.4 mug/g creatinine, 9.5%, 14.4%, and 75.6%, respectively.

17 Age, bilirubin, INR, and creatinine (ABIC) score was B or C in 83%.

18 Daily peak serum creatinine (adjusted for baseline) values were also asso

19 Creatinine, age, and ankle-brachial index were among the

20 or >/=30% decline in eGFR, doubling of serum creatinine, AKI, and kidney failure, respectively.

21 ed SVR12 experienced an improvement in serum creatinine and a reduction in proteinuria.

22 that is produced from the co-condensation of creatinine and amino acids as meats cook at high tempera

23 had lower values compared to the control for creatinine and blood urea nitrogen.

24 e 3 acute kidney injury and daily peak serum creatinine and both delirium and coma.

25 3811321 and rs6565887) associated with serum creatinine and clinical outcome.

26 eveal significant associations with baseline creatinine and contrast volume.

27 est association with 12-month eGFR, and POD5 creatinine and creatinine reduction between POD1 and POD

28 After adjustment for both creatinine and cystatin C levels, higher discharge creat

29 , by functional markers of filtration (serum creatinine and cystatin C).

30 Monitoring of creatinine and immunosuppressive drug concentrations, su

31 r, more often white, and had higher terminal creatinine and KDPI than group 1 (all P < 0.05).

32 The relationship between creatinine and longer term mortality might be particular

33 in neutrophil levels and increases in serum creatinine and low-density lipoprotein cholesterol level

34 ot associated with obesity, and that urinary creatinine and osmolality may be colliders on the causal

35 rs) urinary concentrations were obtained for creatinine and phenol metabolites: enterolactone, genist

36 endpoint was the change of serum bilirubin, creatinine and serum BUN levels before and after the fir

37 ildren when 6-12 y old, adjusted for urinary creatinine and specific gravity, respectively.

38 e difference between baseline and peak serum creatinine and staged according to Kidney Disease Improv

39 rs, we compared ICU discharge cystatin C and creatinine and their association with 1-year mortality.

40 a rapid increase in circulating amino acids, creatinine and urea compared with breast-fed infants.

41 otected against mild renal IRI, with reduced creatinine and urea levels compared with wild type litte

42 after reperfusion for renal function (serum creatinine and urea), complement deposition (C3b/c and C

43 phometry and the utility of measuring plasma creatinine and urinary albumin, has been almost entirely

44 We also assessed 10 creatinine and urine output-based SGF definitions relati

45 s (111 had AKI, defined as doubling of serum creatinine) and ascertained outcomes in the correspondin

46 toxicity (hemoglobin, leukocytes, platelets, creatinine), and immunohistochemical analysis of the kid

47 of >/=30% decline in eGFR, doubling of serum creatinine, and AKI; however, apixaban did not have a st

48 of hemoglobin A1C, cholesterol, hemoglobin, creatinine, and alkaline phosphatase.

49 xygen extraction, a lower decrement of serum creatinine, and higher levels of NGAL and ET-1 were asso

50 e sex, current smoking, statin use, elevated creatinine, and higher lipids were associated with great

51 -TG mice had even greater increases in urea, creatinine, and KIM-1 levels and more tubular injury and

52 , Sequential Organ Failure Assessment score, creatinine, and PCO2 were associated with higher high-se

53 ng were age >75 years, anemia, raised plasma creatinine, and planned long-term anticoagulation.

54 also had elevated blood levels of sodium and creatinine, and reduced levels of random glucose and hae

55 D-fibroblast growth factor 23 (FGF23) axis, creatinine, and renal tubular reabsorption of phosphate

56 Hypertriglyceridemia and higher creatinine are the key factors associated with advanced

57 Using plasma creatinine as outcome could reduce the sample size in tr

58 This is partly because the use of serum creatinine as the comparator has several limitations and

59 re compared with other renal injury markers (creatinine, aspartate transaminase, and heart-type fatty

60 ucose at admission >10.6 mmol/l (191 mg/dl), creatinine at admission >132.6 mumol/l (1.5 mg/dl), Thro

61 ) as well as smaller mean increases in serum creatinine at week 48 (0.01 mg/dL [0.00-0.02] vs 0.03 mg

62 traditional risk factors plus statin use and creatinine (base model).

63 l hazards models to quantify associations of creatinine-based eGFR, urine albumin-to-creatinine ratio

64 sease (CKD) resulting from the inaccuracy of creatinine-based estimates of glomerular filtration rate

65 1), proadrenomedullin (beta=0.171; P<0.001), creatinine (beta=0.118; P=0.003), sodium (beta=0.101; P=

66 ultaneous analysis of immunosuppressants and creatinine can replace conventional venous sampling in d

67 Median creatinine change did not differ among patients receivin

68 eved Css,avg >/=2mg/L; but for patients with creatinine clearance >/=80mL/min target attainment was <

69 individuals with cardiovascular disease and creatinine clearance >30 ml/min) and examined post hoc t

70 n a non-dialysis day), >80% of patients with creatinine clearance <80mL/min achieved Css,avg >/=2mg/L

71 Estimated creatinine clearance (Cockcroft-Gault) from baseline out

72 9 mg kg(-1)) did not change MAP, HR, RBF, or creatinine clearance (CrCl) in SD rats (n = 7).

73 data from 214 adult critically-ill patients (creatinine clearance 0-236mL/min; 29 receiving renal rep

74 sed a transient rise in plasma Pi levels and creatinine clearance and an increase in phosphaturia wit

75 parathyroidectomized rats also led to higher creatinine clearance and lower plasma calcium levels but

76 Surprisingly, renal creatinine clearance as estimated from mass, age, and pl

77 Patients with creatinine clearance below 30 were excluded.

78 Estimated renal creatinine clearance correlated with the extent of activ

79 5 times the upper limit of normal or less, a creatinine clearance of at least 30 mL/min, and a Karnof

80 r at least 6 months before enrolment and had creatinine clearance of at least 50 mL/min.

81 r at least 6 months before enrolment and had creatinine clearance of at least 50 mL/min.

82 prehensive metabolic panel with a calculated creatinine clearance of more than 60 mL per minute.

83 The creatinine clearance on day 4 was increased in NEVKP-pre

84 ared kidneys, we also quantified the average creatinine clearance rate per glomerulus.

85 nt-related concern, then patients with lower creatinine clearance values of > 30 mL/min should be inc

86 polycystic kidney disease (ADPKD; estimated creatinine clearance, >/=60 ml per minute), the vasopres

87 The PRECISE-DAPT score (age, creatinine clearance, haemoglobin, white-blood-cell coun

88 enal function criteria should enable liberal creatinine clearance, unless the investigational agent i

89 HS diet did not affect creatinine clearance.

90 d be needed to achieve a desired Css,avg and creatinine clearance.

91 Two metrics, a rise in serum creatinine concentration and a decrease in urine output,

92 However, mean serum creatinine concentration and albuminuria remained lower

93 ake, ES rats still showed a lower mean serum creatinine concentration and less albuminuria, as well a

94 eatinine plasma concentration in mumol/L) = (creatinine concentration in DBS in mumol/L)/0.73, with a

95 ion rate, manifested by an increase in serum creatinine concentration or oliguria, and classified by

96 Current expressions based on serum creatinine concentration overestimate kidney function in

97 AKI was defined as rise in serum creatinine concentration to 1.5-fold above baseline.

98 However, serum creatinine concentration, albuminuria, and glomerular ex

99 zard model adjusted for age, diabetes, serum creatinine concentration, urinary albumin concentration,

100 AKI that induced a similar increase in serum creatinine concentration.

101 < 0.001) and presented with higher admission creatinine concentrations (1.21 +/- 0.09 vs 0.81 +/- 0.0

102 ined data on age, sex, height, weight, serum creatinine concentrations, and results for GFR from chro

103 ocioeconomic, lifestyle factors, and urinary creatinine concentrations, BPA, but not BPF or BPS, was

104 hour collection were analyzed for sodium and creatinine concentrations.

105 ge glomerular filtration rate estimated from creatinine consistently overestimated follow-up glomerul

106 ssociations of natural logarithm transformed creatinine-corrected urinary vanadium (Ln-vanadium) conc

107 or obesity-related outcomes, controlling for creatinine could induce collider stratification bias.

108 on [DGF] before day 90) were recorded; serum creatinine (Cr) at day 90 was defined as baseline.

109 computed tomography (CT) and for whom serum creatinine (Cr) levels were obtained within 72 hours bef

110 Compared with creatinine criteria alone, incorporating UO into the dia

111 dney Disease/Improving Global Outcomes serum creatinine criteria.

112 In contrast to creatinine, cystatin C consistently associated with long

113 , and a latent variable for kidney function (creatinine, cystatin C, beta2-microglobulin).

114 L/min/1.73 m2, calculated using the combined creatinine-cystatin C CKD-Epidemiology Collaboration Equ

115 orrelated with increases in endothelin-1 and creatinine/cystatin C, respectively.

116 Conversely, creatinine demonstrated a J-shaped relationship with mor

117 stopathologic findings, with increased serum creatinine detected only in the ReninAAV-treated db/db m

118 During ICU admission, serum cystatin C and creatinine diverged, so that by ICU discharge, almost tw

119 s (KDIGO grade 1: n = 3, grade 3: n = 1) but creatinine/eGFR returned to baseline values in all patie

120 I) equations, we compared GFR estimated from creatinine (eGFRcreat), cystatin C (eGFRcys), and both (

121 The maximum creatinine elevation was on day 2 after injury (mg/dL; m

122 Clinical AKI, measured by serum creatinine elevation, is associated with long-term risks

123 ndrome; and a composite of doubling of serum creatinine, ESRD, or death between 100 Rtx-treated patie

124 Levels of oxygen consumption, extraction, creatinine fall and fractional excretion of sodium were

125 While serum creatinine fell at 12 hours, serum cystatin C increased,

126 ies as those of Ga2 for comparison, and with creatinine for sample normalization.

127 re observed with lung function, haemoglobin, creatinine, glucose levels or resting blood pressure mea

128 pressure, body mass index, and cholesterol, creatinine, glucose, insulin, triglycerides, and urea le

129 l species (human serum albumin, neurotensin, creatinine, glycine, and alanine) were retained in the s

130 arette use, diabetes, hypertension, terminal creatinine greater than 1.5 mg/dL and AB blood type.

131 renal function, defined as a rise in plasma creatinine >/=26.5 mumol/l or 50% higher than the admiss

132 te <60 mL/min per 1.73 m(2) or urine albumin/creatinine >30 mg/g) and available echocardiogram-derive

133 Plasma creatinine had strong longitudinal correlations with the

134 r SGF definitions, postoperative day (POD) 7 creatinine had the strongest association with 12-month e

135 0.66 to 0.89; p < 0.001), doubling of serum creatinine (HR: 0.62; 95% CI: 0.40 to 0.95; p = 0.03), a

136 llows the fast and accurate determination of creatinine in real samples with minimal sample manipulat

137 of this novel sensor is tested by measuring creatinine in real urine samples (N=50) and comparing th

138 The miR-21/creatinine in the urine from day 4 was significantly hig

139 hly sensitive and selective determination of creatinine in urine is presented.

140 with acute kidney injury (defined by a serum creatinine increase during hospitalization > 0.3 mg/dL o

141 vents-syncope, pulmonary embolism, and serum creatinine increase-in 3 patients were determined to be

142 Serum creatinine increased from 1.7+/-0.4 mg/dL at 3 months be

143 Persistent congestion trumps serum creatinine increases in predicting adverse heart failure

144 Plasma creatinine, inflammation markers (e.g., TNF-alpha and IL

145 red to confer adverse prognosis, confounding creatinine interpretation in isolation.

146 Plasma creatinine is a predictor of survival in amyotrophic lat

147 However, creatinine is a product of muscle mass and is therefore

148 Plasma creatinine is an inexpensive and easily accessible bioma

149 Postoperative day 7 creatinine is correlated with 12-month eGFR, but large t

150 eletal muscle injury, evidenced by increased creatinine kinase and lactate dehydrogenase, as well as

151 m hemorrhage, cesarean section, and elevated creatinine kinase rates.

152 ciation between daptomycin dose and elevated creatinine kinase.

153 gher resting heart rate, older age, elevated creatinine, larger left atrial volume index, and larger

154 An increase in serum creatinine led to the addition of sirolimus at 3 months

155 as stage 2 or 3 acute kidney injury (plasma creatinine level >/=2 times the baseline level or urine

156 hylaxis without severe kidney disease (serum creatinine level >3 mg/dL; glomerular filtration rate <1

157 idney disease (OR, 2.05; 95% CI, 1.15-3.64), creatinine level (per SD increase; OR, 1.13; 95% CI, 1.0

158 Median baseline serum creatinine level (range) was 1.4 (0.8-2.4) mg/dl, and pr

159 acute kidney injury according to the plasma creatinine level alone failed to identify acute kidney i

160 ic kidney disease (CKD) in children, such as creatinine level and cystatin C-derived estimated glomer

161 albumin-to-creatinine ratio (ACR) and serum creatinine level and more severe renal lesions.

162 e of at least 50% from baseline in the serum creatinine level at 90 days.

163 O criteria and was based on changes in serum creatinine level from hospital days 0 to 2 through hospi

164 arameters were also associated with a raised creatinine level in the donor before organ retrieval.

165 n per cohort) had a mean (SD) baseline serum creatinine level of 1.0 (0.2) mg/dL and more than 20% ha

166 mal level, <142 U/L [2.37 mukat/L]), a serum creatinine level of 93 mumol/L (reference range, 79-125

167 nction defined as return of postintervention creatinine level to baseline.

168 hat GFR was significantly greater, and serum creatinine level was significantly lower in TRPC6 defici

169 io [OR], 1.644; P = 0.021), whereas elevated creatinine level was the only factor associated with adv

170 iltration rate (eGFR), doubling of the serum creatinine level, acute kidney injury (AKI), and kidney

171 STAT activity and resulted in reduced serum creatinine level, albuminuria, and renal histologic chan

172 In adjusted analysis, higher serum creatinine level, black race, older age, and ischemic he

173 lbuminuria, persistent doubling of the serum creatinine level, end-stage renal disease, or death due

174 ain (NFL), the ratio of N-acetylaspartate to creatinine levels (a magnetic resonance spectroscopy neu

175 Increased MDA and plasma creatinine levels also became evident after 4 hours fast

176 oup had higher serum blood urea nitrogen and creatinine levels and a longer electrocardiographic QTc

177 statistically significant decreases in serum creatinine levels compared with levels in animals given

178 ) and with the ratio of N-acetylaspartate to creatinine levels in parietal gray matter (r = -0.352 an

179 ow BD induction, superoxide, MDA, and plasma creatinine levels increased further, whereas GPx activit

180 /=7 days) was estimated using serum urea and creatinine levels of 1,448 samples collected from 1,177

181 underlying kidney disease or abnormal serum creatinine levels on hospital days 0 to 2 were among tho

182 nexin 43+/-) had proteinuria, BUN, and serum creatinine levels significantly lower than those of wild

183 oxygenase 1 expression, and increased plasma creatinine levels were evident.

184 esulted in significant increases in urea and creatinine levels, a small (P<0.05) reduction in ejectio

185 avbeta5 antibody significantly reduced serum creatinine levels, diminished renal damage detected by h

186 e 1 expression, and increased MDA and plasma creatinine levels.

187 presentation at time of index biopsy, serum creatinine levels/renal function over 24 months of follo

188 rence >94 (males) or >80 (females) cm, serum creatinine <1.2 mg/dL, and normoalbuminuria were randomi

189 accuracy when applied to subclinical cases (creatinine, <25% increase from baseline) or had minimal

190 creen or monitor bone mineral density, serum creatinine, magnesium, or vitamin B12.

191 Plasma creatinine may, therefore, increase the power to detect

192 n depending on the prevailing methodology of creatinine measurement, and used linear regression to mo

193 ontrol groups had similar prepregnancy serum creatinine measurements (0.70+/-0.20 versus 0.69+/-0.10

194 a retrospective analysis using the Stockholm creatinine measurements database, which contains informa

195 could be improved by replacing non-targeted creatinine measurements with a standard clinical creatin

196 simple formula-lactate dehydrogenase (U/L) x creatinine (mg/dL)/thrombocytes (10(9) cells per L)-term

197 n with high urinary FSH values (>11.5 mIU/mg creatinine [n = 69]) did not have a significantly differ

198 clinical pregnancy loss in women with higher creatinine- normalized concentrations of MEP, MBP, MEOHP

199 or frontal cortex correlated positively with creatinine-normalized Delta9-tetrahydrocannabinol (THC)

200 nship between cadmium exposure, evaluated by creatinine-normalized urinary cadmium concentration, and

201 1.88; 95% CI, 1.19-2.99), abnormal baseline creatinine (odds ratio, 2.48; 95% CI, 1.59-3.88), and in

202 graft outcomes were similar with mean 1-year creatinine of 1.03 +/- 0.45 versus 0.99 +/- 0.6 (P = 0.4

203 reserved with NEVKP demonstrated lower serum creatinine on days 1 to 7 (P < 0.05) and lower peak valu

204 mproving Global Outcome criteria (changes in creatinine only).

205 was progression CKD, defined as doubling of creatinine or decrease in estimated glomerular filtratio

206 natal intensive care unit; doubling of serum creatinine or increase in CKD stage.

207 st-to-height ratio were observed when either creatinine or osmolality were used to standardize or as

208 lution, including standardization by urinary creatinine, osmolality, and flow rates, and inclusion of

209 Serum creatinine peaked late (24 hr), when clinical recovery w

210 tical concentrations of ATP, ADP, AMP, cAMP, creatinine phosphate and ATP:AMP ratio were increased by

211 GF23 by study week 4, with no differences in creatinine, phosphate, or TRP.

212 0.71-0.76), giving the conversion formula: (creatinine plasma concentration in mumol/L) = (creatinin

213 cystatin C (Pnoninferiority < 0.0001), serum creatinine (Pnoninferiority = 0.0004), and measured glom

214 ystatin C increased, suggestive of decreased creatinine production.

215 01) and rise of cystatin C (Ptrend=0.01) and creatinine (Ptrend<0.001) levels.

216 gorised into quartiles (Q; Q1: </=0.84 mug/g creatinine, Q2: 0.84-1.40 mug/g creatinine, Q3: 1.40-2.9

217 /=0.84 mug/g creatinine, Q2: 0.84-1.40 mug/g creatinine, Q3: 1.40-2.96 mug/g creatinine, Q4: >2.96 mu

218 4-1.40 mug/g creatinine, Q3: 1.40-2.96 mug/g creatinine, Q4: >2.96 mug/g creatinine, with the lowest

219 iopulmonary bypass (R = 0.27), and change in creatinine (R = 0.12).

220 FR] <60 mL/min/1.73m2), albuminuria (albumin/creatinine ratio >/=3 mg/mmol), and proximal renal tubul

221 of patients with baseline urinary albumin-to-creatinine ratio >/=30 mg/g, urinary albumin-to-creatini

222 r 1.73 m(2)), and a 24-hour urine protein-to-creatinine ratio >/=800 mg/g to TGF-beta1 mAb (2-, 10-,

223 tubular dysfunction (retinol-binding protein/creatinine ratio >2.93mug/mmol and/or fractional phospha

224 in per 1.73 m(2) [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]).

225 0 mL.min(-1).1.73 m(-2) and/or urine albumin-creatinine ratio >300 mg/g) at baseline.

226 n(-1).1.73 m(-2)) and baseline urine albumin-creatinine ratio (>300, 30-</=300, <30 mg/g).

227 hibited a substantial increase in albumin-to-creatinine ratio (ACR) and serum creatinine level and mo

228 s of creatinine-based eGFR, urine albumin-to-creatinine ratio (ACR), and dipstick proteinuria with th

229 and fourth quartiles of urinary endotrophin:creatinine ratio (ECR) were independently associated wit

230 7.23; P<0.001); >/=0.30 g/g urine protein-to-creatinine ratio (HR, 2.44; 95% CI, 1.47 to 4.09; P<0.00

231 n (P < 0.001), the increase of urine albumin creatinine ratio (P < 0.01), the fall in glomerular filt

232 Here, we report urinary albumin-to-creatinine ratio (UACR) data for the pooled empagliflozi

233 clearance) was associated with urine albumin/creatinine ratio (UACR) post-HTx in a subgroup of patien

234 /1.73 m(2) and the median urinary protein-to-creatinine ratio (UPCR) 502 (122-1491) mg/g.

235 lacebo, stratified by baseline urine protein creatinine ratio (UPCR).

236 en urine albumin excretion (urine albumin-to-creatinine ratio [UACR]) and genomic regions harboring v

237 n per 1.73 m(2), and median urine protein-to-creatinine ratio [UPCR] =0.20 g/g).

238 glomerular filtration rate, urine albumin-to-creatinine ratio and urine protein-to-creatinine ratio)

239 across categories of eGFR and urine albumin-creatinine ratio at baseline and across the 2 doses stud

240 retion, assessed according to the albumin-to-creatinine ratio calculated from three early-morning uri

241 atinine ratio >/=30 mg/g, urinary albumin-to-creatinine ratio decreased more with canagliflozin 100 m

242 The urine albumin-to-creatinine ratio genome-wide association scan identified

243 agulated thromboembolism; a urine protein to creatinine ratio of less than 1; and measurable disease.

244 r and a statin did not change the albumin-to-creatinine ratio over time.

245 ogical measures FE and urinary metabolite-to-creatinine ratio was lower, but could be improved by rep

246 min-to-creatinine ratio and urine protein-to-creatinine ratio) did not (Rho = -0.222; -0.137; -0.070

247 emographics, baseline eGFR, urine albumin-to-creatinine ratio, comorbidity, and measures of mineral m

248 n groups when stratified by urine albumin-to-creatinine ratio.

249 2 peak, kidney function, or urine albumin-to-creatinine ratio.

250 function was determined via urinary albumin/creatinine-ratio (uACR).

251 atients with AASK-N, with 24-hour protein-to-creatinine ratios (milligrams per milligram) ranging fro

252 onic renal injury, increased urinary albumin/creatinine ratios, and increased tissue oxidative stress

253 renal lesions, and measured urinary albumin/creatinine ratios, tissue oxidative stress levels, and A

254 ated CS-induced increases in urinary albumin/creatinine ratios, tissue oxidative stress levels, endot

255 ith concomitant reductions of 44% in protein/creatinine ratios.

256 me-wide association scan of urine albumin-to-creatinine ratios.

257 values in the upper third of the albumin-to-creatinine ratios; 443 were randomly assigned in a place

258 with 12-month eGFR, and POD5 creatinine and creatinine reduction between POD1 and POD2 demonstrated

259 S-DGF to a definition that combines impaired creatinine reduction in the first 48 hours or greater th

260 Conversely, lower creatinine relative to cystatin C appeared to confer adv

261 /0.72 micromol/L and 3.39/4.30 micromol/mmol creatinine, respectively.

262 0.004 compared with 0.041 +/- 0.004 mumol/g creatinine, respectively; P = 0.0009) and had 52% lower

263 .6 +/- 0.1 compared with 1.0 +/- 0.1 mumol/g creatinine, respectively; P = 0.002), 63% less hexadeute

264 +/- 0.02 compared with 0.13 +/- 0.02 mumol/g creatinine, respectively; P = 0.002), and 58% less d6-al

265 ded because they had HIV (n=27) or grade 2-4 creatinine results (n=6).

266 using a standardized definition -i.e., serum creatinine rise of >/=0.3 mg/dL (26.5 mcmol/L) or >/=50%

267 When serum creatinine (SC) and UO criteria were used, 604 patients

268 , bilirubin, international normalized ratio, creatinine scores), complete abstinence was independentl

269 ears with type 1 or type 2 diabetes, a serum creatinine (SCr) level of 1.3-3.3 mg/dl for women and 1.

270 g/dl) or a relative (>25%) increase in serum creatinine (sCr).

271 72 patients were available for validation of creatinine, TaC and CsA, respectively.

272 tinine measurements with a standard clinical creatinine test.

273 ients in rate of decline was lower in plasma creatinine than in ALS functional rating scale-Revised (

274 etween plasma hemoglobin level and change in creatinine that varied by age (overall [R = 0.12; p < 0.

275 improved laboratory variables (bilirubin and creatinine), the short-term mortality (up to day 14) of

276 ing Pearson's correlation coefficient, serum creatinine-to-serum cystatin C ratio was found to be the

277 ulses or in case of return to baseline serum creatinine together with reduction of donor-specific HLA

278 doxyl sulfate, p-cresol sulfate, kynurenine, creatinine, urate) include two "drug" transporters of th

279 7 was associated with higher levels of serum creatinine, uric acid, calcium and lower urine pH level.

280 Outcome measures included serum creatinine, urine microprotenuira, and immunohistomorpho

281 that included age, sex, and discharge serum creatinine value alone (integrated discrimination improv

282 ity of acute kidney injury, and higher serum creatinine value at discharge.

283 older age, female sex, higher baseline serum creatinine value, albuminuria, greater severity of acute

284 with a marginal functional benefit in 1-year creatinine values (P = .044), with adjusted averages of

285 Plasma creatinine values were lower in the hyperoxia group duri

286 nts, 194 (2.3%) were excluded due to missing creatinine values, no or an incomplete coronary angiogra

287 e diagnosis of the index admission and serum creatinine values: 1) acute kidney injury, 2) pneumonia,

288 tients were excluded if their baseline serum creatinine was >1.2mg/dL or they were receiving renal re

289 The last median serum creatinine was 128.2 +/- 40.8 mumol/L.

290 ance as estimated from mass, age, and plasma creatinine was a significant predictor of BFI on the tot

291 HIV testing was done monthly and serum creatinine was assessed every 3 months.

292 A corrected creatinine was derived from the mGFR after application o

293 ter onset of therapy-induced increased serum creatinine was not superior to standard care and resulte

294 nine and cystatin C levels, higher discharge creatinine was then associated with lower long-term mort

295 For creatinine, we found y = 0.73x - 1.55 (95% confidence in

296 ne, muscle strength and survival with plasma creatinine were assessed.

297 up glomerular filtration rate estimated from creatinine, whereas ICU discharge glomerular filtration

298 with other target molecules, such as urea or creatinine, while maintaining a low detection limit (0.0

299 ease (CKD) monitoring in primary care, serum creatinine with estimated glomerular filtration rate and

300 1.40-2.96 mug/g creatinine, Q4: >2.96 mug/g creatinine, with the lowest quartile set as reference) w